T1	Participants 0 95	Evaluating erectile dysfunction: oral sildenafil versus intracavernosal injection of papaverine
T2	Participants 390 462	Men with erectile dysfunction were randomized into two groups of 25 each
T3	Participants 477 483	25 men
T4	Participants 557 567	another 25
T5	Participants 1425 1445	erectile dysfunction
